INSPIRE VETERINARY PARTNERS, INC. (IVPR): Nasdaq/NYSE listing notice — Inspire Veterinary Partners receives Nasdaq delisting notice for negative equity of ($788,259); hearing May 14

INSPIRE VETERINARY PARTNERS, INC.

Stockholders' equity of ($788,259) as of Dec 31, 2023 fails Nasdaq listing rule requirements.
Company also does not meet alternatives of market value or net income from continuing operations.
Hearing before Nasdaq Panel scheduled for May 14, 2024; securities not suspended pending determination.
Company plans to present a compliance plan at the hearing to address the deficiency.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5250(c)(1)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: stockholders equity
Rules: 5250(c)(1)

Exact text from the filing

April 11, 2024, Inspire Veterinary Partners, Inc. (the “Company”) received a staff determination from The Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of ($788,259) as reported in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 as filed with the Securities and Exchange Commission, the Company does not meet the alternatives of market value of listed securities or net income from continuing operations. As such, the Company no longer complies with Nasdaq’s Listing Rule (the “Rule”). Accordingly, this matter se

View on SEC.gov

1 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

INSPIRE VETERINARY PARTNERS, INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-033037

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.